The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Dapsone (NDC 70771-1980). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 70771-1979-3 in bottle of 30 tablets
Dapsone Tablets USP, 25 mg
Rx only
30 tablets
25 mg Label (A4ce6655 3e02 434d 87ad 5bcec90202c1 01)
NDC 70771-1980-3 in bottle of 30 tablets
Dapsone Tablets USP, 100 mg
Rx only
30 tablets
100 mg Label (A4ce6655 3e02 434d 87ad 5bcec90202c1 02)
* Please review the disclaimer below.
